These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11857497

  • 1. Methylation-specific PCR for detection of neoplastic DNA in biopsy washings.
    Goessl C, Müller M, Heicappell R, Krause H, Schostak M, Straub B, Miller K.
    J Pathol; 2002 Mar; 196(3):331-4. PubMed ID: 11857497
    [Abstract] [Full Text] [Related]

  • 2. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C, Krause H, Müller M, Heicappell R, Schrader M, Sachsinger J, Miller K.
    Cancer Res; 2000 Nov 01; 60(21):5941-5. PubMed ID: 11085508
    [Abstract] [Full Text] [Related]

  • 3. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.
    Cancer Epidemiol Biomarkers Prev; 2002 May 01; 11(5):445-50. PubMed ID: 12010858
    [Abstract] [Full Text] [Related]

  • 4. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML, Nakayama M, Lee SM, De Marzo AM, Nelson WG.
    Urology; 2004 Feb 01; 63(2):414-8. PubMed ID: 14972513
    [Abstract] [Full Text] [Related]

  • 5. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG.
    Clin Cancer Res; 2003 Jul 01; 9(7):2673-7. PubMed ID: 12855646
    [Abstract] [Full Text] [Related]

  • 6. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV, Guo Z, Epstein JI, Sidransky D.
    J Urol; 2003 Mar 01; 169(3):1138-42. PubMed ID: 12576869
    [Abstract] [Full Text] [Related]

  • 7. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.
    Clin Chim Acta; 2004 Dec 01; 350(1-2):181-8. PubMed ID: 15530476
    [Abstract] [Full Text] [Related]

  • 8. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 9. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D.
    Clin Cancer Res; 2001 Sep 29; 7(9):2727-30. PubMed ID: 11555585
    [Abstract] [Full Text] [Related]

  • 10. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
    Eilers T, Machtens S, Tezval H, Blaue C, Lichtinghagen R, Hagemann J, Jonas U, Serth J.
    Prostate; 2007 May 15; 67(7):757-63. PubMed ID: 17373715
    [Abstract] [Full Text] [Related]

  • 11. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R, Jerónimo C.
    Eur Urol; 2004 Nov 15; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [Abstract] [Full Text] [Related]

  • 12. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 15; 7(6):531-6. PubMed ID: 9641498
    [Abstract] [Full Text] [Related]

  • 13. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK, Chu DC, Tzou RD, Liou SI, Chia JH, Sun CF.
    Cancer Detect Prev; 2007 Jun 15; 31(1):59-63. PubMed ID: 17291695
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.
    Clin Cancer Res; 2005 Jun 01; 11(11):4037-43. PubMed ID: 15930338
    [Abstract] [Full Text] [Related]

  • 16. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
    Chu DC, Chuang CK, Fu JB, Huang HS, Tseng CP, Sun CF.
    J Urol; 2002 Apr 01; 167(4):1854-8. PubMed ID: 11912447
    [Abstract] [Full Text] [Related]

  • 17. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.